Download this datacard
Overview
Lobbying Costs
350,000€
Financial year: May 2014 - Apr 2015
Lobbyists (Full time equivalent)
1.75 Fte (4)
Lobbyists with EP accreditation
3
High-level Commission meetings
6
Lobbying Costs over the years
-
Info
Medtronic (MDT)
EU Transparency Register
503957813562-10 First registered on 29 Apr 2014
Goals / Remit
Medtronic is a global healthcare solutions company committed to improving the lives of people through our medical technologies, services, and solutions. Medtronic offers innovative therapies in our core technologies - Electrical Stimulation, Implantable Structural Devices, Targeted Drug and Biologics Delivery, Powered and Advanced Energy Instruments, Surgical Navigation and Imaging and Patient and Device Management - to fulfill our Mission of alleviating pain, restoring health, and extending life.
We have a deep understanding of many universal healthcare challenges and we are using our experience, extensive partnerships, and the passion of 80,000+ employees to improve healthcare by addressing the needs of more people, in more ways and in more places around the world.Main EU files targeted
organisation:
Revison of the medical devices directives and in vitro medical devices directive. Reform of the EU legal framework on the protection of personal data. The Transatlantic Trade and Investment Partnership (TTIP) and other proposed free trade agreements between the European Union and Third countries. Safety and environmental legislation including but not limited to the Restriction of Hazardous Substances (RoHS) directive and the REACH regulation. European Parliament’s Special Committee on Tax Rulings (TAXE). The European Commission’s Tax Transparency Package.
Non-financial reporting legislation. Active and Healthy Ageing policy. MEPs Against Cancer and the MEP Heart Group; MEP interest group on Brain, Mind and Pain; MEP Interest Group on Patient Access to Health Care.The Cross-border Healthcare directibve. e-Health. HTA network, EUnetHTA. EU financial package. EU Public Procurement directive. Research, Science and Innovation Commissioner’s top 3 priorities (1) establishing the right framework conditions for innovation and R&D in Europe, (2) science diplomacy and (3) the Horizon 2020 programme. Contribute, through industry association, to The EU’s Health Policy Forum. Chronic diseases policy - Addressing the burden in the EU.Address
Head Office
Medtronic Parkway, 710
Minneapolis MN 55432-5604
UNITED STATESEU Office
Burg. Etienne Demunterlaan 5
Jette 1090
BELGIUM -
People
Total lobbyists declared
4
Employment time Lobbyists 75% 1 50% 1 25% 2 Lobbyists (Full time equivalent)
1.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 29 Mar 2016
Name Start date End Date Ms Valeria Fagone 08 May 2019 05 Feb 2020 Ms Valeria Fagone 08 Jun 2018 08 May 2019 Ms Valeria Fagone 04 Jan 2017 21 Dec 2017 Ms JEANETTE DRIELSMA 22 Oct 2016 21 Oct 2017 Mr Oliver Daniel BISAZZA 10 May 2016 07 May 2017 Ms Valeria Fagone 21 Jul 2015 17 Jul 2016 Mr MARK TAYLOR 16 Jul 2015 14 Jul 2016 Mr Oliver Daniel BISAZZA 30 Apr 2015 28 Apr 2016 Mr MARK TAYLOR 16 Jul 2014 14 Jul 2015 Complementary Information
None declared
Person in charge of EU relations
Ms Valeria Fagone (Senior Director Government Affairs)
Person with legal responsibility
Mr Robert ten Hoedt (Executive Vice-President & President EMEA)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Eucomed
EDMA
MedTech Europe
EU British Chamber of CommerceMember organisations
None declared
-
Financial Data
Closed financial year
May 2014 - Apr 2015
Lobbying costs for closed financial year
350,000€
Other financial info
None
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
Activities together with and in support of MedTech Europe.
Other activities
Medical devices, Diagnostics, Consumer Affairs, Consumer products, External Trade, Innovation, Intellectual Property, Internal Market, Justice and Fundamental Rights, Public Health, Research and Development, Sustainability – including environmental sustainability, Taxation
Meetings
Meetings
6 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 04 Nov 2019 Location Brussels Subject Medical devices Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Vinciunas (Cabinet member)
-
Date 22 Mar 2019 Location Brussels, Belgium Subject Commission priorities in 2019 Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Vinciunas (Cabinet member)
-
Date 01 Jul 2015 Location Brussels Subject Developments in medical devices market Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Nele Eichhorn (Cabinet member)
-
Date 05 Mar 2015 Location Brussels Subject Intro meeting Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Fabrice Comptour (Cabinet member)
- Rolf Carsten Bermig (Cabinet member)
Other Lobbyists -
Date 04 Mar 2015 Location Brussels Subject Medical device & TTIP Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)
-
Date 04 Mar 2015 Location Brussels Subject Medical device and TTIP Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Cécile Billaux (Cabinet member)